ARCHIVES

FDA Approves Xeloda For Colon Cancer; Phase III Data Not Reviewed By ODAC.

This article is from The Cancer Letter archive.

Vol. 27 No. 18 | May 4, 2001

Download PDF Visit The Full Archive

Related Articles

Gene Delivery System Targets Tumor Blood Vessels In Dogs

March 27, 2009

Democrats Say Bush Budget Neglects NSF And NASA.

March 23, 2001

In Brief: Baque Heads Cancer Control Science Programs; Joftes, Davignon T Retire; Schepartz Returns

September 29, 1989

UPCI Puts the Cancer Letter on its Intranet for Employees

May 5, 2000

Hey Doc, Wanna Score Some Leucovorin? Drugs Available at 80 Times the Price

October 14, 2011

New Safety Concerns On ESAs Prompt FDA To Consult ODAC Again.

January 11, 2008